Logo

Amoy Diagnostics

AmoyDx PCR Panel Receives Japanese Approval as CDx for Non-Small Cell Lung Cancer Therapies

The Japanese MHLW approved the real-time PCR-based test as a CDx to detect four driver genes for nine associated NSCLC targeted therapies.

AmoyDx, AstraZeneca Strike Ovarian Cancer Companion Diagnostic Alliance

The companies have worked together on a number of other cancer-related projects, including a companion diagnostic for the ovarian cancer treatment olaparib.

Amoy Diagnostics, Merck KGaA Partner for Lung Cancer Companion Diagnostic Development in China

AmoyDx will develop and seek regulatory approval in China for a lung cancer PCR panel to be used with Merck's MET inhibitor tepotinib.

Amoy Diagnostics, Haihe Pharmaceutical Ink Agreement to Codevelop CDx for Lung Cancer Treatment

Amoy will develop its AmoyDx Pan Lung Cancer PCR Panel (9-in-1 Plus) as a companion diagnostic test for Haihe's MET kinase inhibitor Glumetinib.

AmoyDx Strikes CDx Development Deal for Merck KGaA Cancer Drug

AmoyDx aims to develop a companion diagnostic for Merck KGaA's non-small cell lung cancer treatment Tepmetko, which was recently approved in Japan.

Mar 25, 2020

AmoyDx, Janssen Research and Development Partner on NGS-Based Companion Diagnostic

Jan 3, 2020

Massachusetts Startup Focuses on Long-Read Sequencing Technology
Premium

Nov 25, 2019

AmoyDx, Eisai Form CDx Development Alliance

Oct 4, 2019

In Brief This Week: Thermo Fisher, HalioDx, OncoCyte, Amoy Diagnostics, More

Jun 24, 2019

AmoyDx, Premia Partner With Loxo on Genetic Testing for Cancer Therapy

Mar 1, 2019

AmoyDx Wins Chinese Regulatory Approval for BRCA Mutation Test

Jan 29, 2019

AmoyDx, Sanomics Ink Deal for Multigene Mutation Detection Kit

Oct 12, 2018

AmoyDx Lung Cancer CDx Approved in South Korea

Jan 29, 2018

AmoyDx, Medikonia Ink MDx Distribution Deal

Jan 22, 2018

AmoyDx Wins Chinese Approval for Lung Cancer Liquid Biopsy CDx

May 16, 2017

Amoy Dx Partners With Canbridge on CDx Development

Feb 3, 2017

Japan Regulators Approve AmoyDx's Lung Cancer CDx

Jul 28, 2016

Merck KGaA, AmoyDx Partner on Colorectal Cancer Test for Chinese Market

Oct 1, 2015

AmoyDx, Illumina Partner to Develop NGS Cancer Diagnostics for Chinese Clinical Oncology Market

Oct 24, 2014

Amoy Diagnostics Obtains CE Mark for Cancer Mutation Assays

Oct 17, 2014

MoBiTec to Distribute Amoy's MDx Products in Germany

Sep 3, 2014

Chinese Regulators Approve AmoyDx's ALK, ROS1 Gene Fusion Detection Kits

Aug 29, 2013

OxOnc to Use Amoy Gene Fusion Kits in Trial of Pfizer Drug

Mar 20, 2013

AmoyDx Cancer Detection Kit Approved by Chinese Regulators

Jan 25, 2013

In Brief This Week: Syapse; Amoy Diagnostics; Precision Therapeutics, Med BioGene; Abbott

Breaking News
The Scan

Interfering With Invasive Mussels

The Chicago Tribune reports that researchers are studying whether RNA interference- or CRISPR-based approaches can combat invasive freshwater mussels.

Participation Analysis

A new study finds that women tend to participate less at scientific meetings but that some changes can lead to increased involvement, the Guardian reports.

Right Whales' Decline

A research study plans to use genetic analysis to gain insight into population decline among North American right whales, according to CBC.

Science Papers Tie Rare Mutations to Short Stature, Immunodeficiency; Present Single-Cell Transcriptomics Map

In Science this week: pair of mutations in one gene uncovered in brothers with short stature and immunodeficiency, and more.